228
Participants
Start Date
November 30, 2015
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
CAM2038 q1w or q4w exposure to SL BPN/NX
CAM2038 q1w or q4w new to BPN treatment
Taipei City Hospital, Taipei
Jinan Psychiatric Center, Ministry of Health and Welfa, Tainan City
Clinexpert Kft, Budapest
XVI. Kerület Kertvárosi Egészségügyi Szolgálata, Addiktológia, Budapest
Royal Prince Alfred Hospital, Sydney
Behandlingscenter Odense, Odense
Drug & Alcohol Services SA Drug and Alcohol Services, Norwood
Center for Misbrugsbehandling, Aarhus
STARS/Columbia University, New York
Frost Medical Group, LLC, Conshohocken
Dr Vijapura and Associates, Jacksonville
TRY Research, Maitland
Studikum - Zentrum fur Klinische Studien im Praxiszentrum Friedrichsplatz, Kassel
Parkway Medical Center, Birmingham
Haleyville Clinical Research LLC, Haleyville
Boyett Health Services Inc, Hamilton
China Medical University Hospita, Taichung
Klinik fur Abhangiges Verhalten und Suchtmedizin Zentralinstitut, Mannheim
Praxisgemeinschaft, Stuttgart
Centrallasarettet Vasteras, Västerås
Gemeinschaftspraxis Schnaitmann/Schaffert Salzstrasse, Heilbronn
Psychosoziale Begleitung - Praxis Boniakowski, Regensburg
Stanley Street Treatment and Resources Inc, Fall River
Wellness and Research Center, Belvidere
Comprehensive Clinical Research, Berlin
Newcastle Community Health Services, Newcastle
South Eastern Sydney Local Health District (SESLHD), Sydney
Metadonsektionen, Stockholm
Blackberry Centre Blackberry Hill Hospital, Fishponds
Hellesdon Hospital The Weavers Centre, Hellesdon
NHS Tayside, Dundee
Lambeth Drug and Alcohol Service Lorraine Hewitt House, London
Lead Sponsor
Braeburn Pharmaceuticals
INDUSTRY